Literature DB >> 16023595

Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling.

Qinghua Zeng1, Shenglin Li, Douglas B Chepeha, Thomas J Giordano, Jong Li, Honglai Zhang, Peter J Polverini, Jacques Nor, Jan Kitajewski, Cun-Yu Wang.   

Abstract

While significant progress has been made in understanding the induction of tumor vasculature by secreted angiogenic factors, little is known regarding contact-dependent signals that promote tumor angiogenesis. Here, we report that the Notch ligand Jagged1 induced by growth factors via mitogen-activating protein kinase (MAPK) in head and neck squamous cell carcinoma (HNSCC) cells triggered Notch activation in neighboring endothelial cells (ECs) and promoted capillary-like sprout formation. Jagged1-expressing HNSCC cells significantly enhanced neovascularization and tumor growth in vivo. Moreover, the level of Jagged1 was significantly correlated with tumor blood vessel content and associated with HNSCC development. Our results elucidate a novel mechanism by which the direct interplay between tumor cells and ECs promotes angiogenesis through MAPK and Notch signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023595     DOI: 10.1016/j.ccr.2005.06.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  144 in total

1.  Rabconnectin-3 is a functional regulator of mammalian Notch signaling.

Authors:  Nilay Sethi; Yan Yan; Debra Quek; Trudi Schupbach; Yibin Kang
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

2.  Linking model systems to cancer therapeutics: the case of Mastermind.

Authors:  Barry Yedvobnick; Ken Moberg
Journal:  Dis Model Mech       Date:  2010-07-27       Impact factor: 5.758

3.  Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.

Authors:  Kyla Driscoll Carroll; Wei Bu; Diana Palmeri; Sophia Spadavecchia; Stephen J Lynch; Salvatore A E Marras; Sanjay Tyagi; David M Lukac
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth.

Authors:  Christine F O'Neill; Sumithra Urs; Christina Cinelli; Alexis Lincoln; Robert J Nadeau; Ruth León; Jessica Toher; Carla Mouta-Bellum; Robert E Friesel; Lucy Liaw
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

Review 5.  Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.

Authors:  Wen Shi; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

6.  Derived vascular endothelial cells induced by mucoepidermoid carcinoma cells: 3-dimensional collagen matrix model.

Authors:  Sen Yang; Li-juan Guo; Qing-hong Gao; Ming Xuan; Ke Tan; Qiang Zhang; Yu-ming Wen; Chang-mei Wang; Xiu-fa Tang; Xiao-yi Wang
Journal:  J Zhejiang Univ Sci B       Date:  2010-10       Impact factor: 3.066

7.  Overexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway.

Authors:  Xiujie Li; Ezequiel Calvo; Marc Cool; Pavel Chrobak; Denis G Kay; Paul Jolicoeur
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

8.  Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma.

Authors:  Nibal Zaghloul; Sonia L Hernandez; Jae-O Bae; Jianzhong Huang; Jason C Fisher; Alice Lee; Angela Kadenhe-Chiweshe; Jessica J Kandel; Darrell J Yamashiro
Journal:  Int J Oncol       Date:  2009-02       Impact factor: 5.650

9.  Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.

Authors:  Bilal Bin Hafeez; Vaqar Mustafa Adhami; Mohammad Asim; Imtiaz A Siddiqui; Kumar M Bhat; Weixiong Zhong; Mohammad Saleem; Maria Din; Vijayasaradhi Setaluri; Hasan Mukhtar
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

Review 10.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.